How Much Did Comet Bio Raise?
Funding & Key Investors

Comet Bio, a pioneer in the food technology sector, has successfully secured a major strategic investment, bringing its total capital raised to $22M. This latest infusion of $22M marks a significant milestone in the company's growth trajectory, reinforcing its position as a leader in sustainable ingredient manufacturing. By leveraging its proprietary upcycling technology, Comet Bio continues to attract high-profile institutional backing, signaling strong market confidence in its ability to scale prebiotic fiber and low-sugar sweetener production for the global food and beverage industry.

What is Comet Bio?

Comet Bio
Hospitals & Physicians ClinicsMedical Practice ManagementConsumer Services

Headquartered across London, Ontario, and Schaumburg, Illinois, Comet Bio operates at the intersection of sustainability and food science. The company specializes in transforming agricultural byproducts into high-value, functional ingredients. Its flagship product, Arrabina Arabinoxylan Plant Fiber Extract, serves as a premium prebiotic fiber, while its Sweeterra syrup line offers a sustainable, lower-sugar alternative to traditional sweeteners. By optimizing the supply chain through upcycling, Comet Bio addresses the dual demand for healthier consumer products and environmentally responsible manufacturing processes, positioning itself as a critical player in the future of food systems.

How much funding has Comet Bio raised?

Comet Bio has raised a total of $22M across 1 funding round:

2021

Series C

$22M

Series C (2021): $22M with participation from BDC Capital, Open Prairie Ventures, Sofinnova Partners, and Louis Dreyfus Company

Key Investors in Comet Bio

Sofinnova Partners

A leading European venture capital firm in life sciences, specializing in healthcare and sustainability, with a focus on building transformative innovations across the entire value chain.

Open Prairie Ventures

A private equity fund management firm with a strong focus on agriculture and rural America, aiming to enhance capital accessibility in underserved markets.

Louis Dreyfus Company

A global merchant and processor of agricultural goods, providing deep industry expertise in food, beverages, and bioenergy production.

What's next for Comet Bio?

With this major enterprise-level funding, Comet Bio is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The capital will likely be deployed to scale production capacity for its Sweeterra and Arrabina product lines, meeting the rising demand for clean-label, sustainable ingredients. As the company transitions from its current growth phase toward broader market penetration, it will focus on strengthening its strategic partnerships with global food manufacturers. This financial backing provides the necessary runway to solidify its competitive advantage in the functional food market, ensuring that its upcycling technology remains at the forefront of the industry's shift toward circular economy models.

See full Comet Bio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsPhysicians Clinics
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Dental Practice ManagementHospitals & Physicians Clinics
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMedical Laboratories & Imaging Centers

Frequently Asked Questions Regarding Comet Bio Financial Insights

What are the most recent funding rounds that Comet Bio has completed, and what were the funding rounds?
Comet Bio has recently completed 1 funding rounds: Series C on Jul 21, 2021.
What is the total amount of funding Comet Bio has raised to date?
Comet Bio has raised a total of $22M in funding to date.
How many funding rounds has Comet Bio completed?
Comet Bio has completed 1 funding rounds.
How much funding did Comet Bio raise in its most recent funding round?
Comet Bio raised $22M in its most recent funding round.
Who are the lead investors in Comet Bio's latest funding round?
The lead investor in Comet Bio's latest funding round was BDC Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Comet Bio's history?
The largest funding round in Comet Bio's history was $22M.
See more information about Comet Bio